Study Objectives: Multiple sleep onset rapid eye movement (R) periods (SOREMPs) and a mean sleep latency of ≤8 minutes on the multiple sleep latency test (MSLT) are diagnostic criteria of narcolepsy (NC), but also occur in other conditions with increased sleep pressure, including insufficient sleep syndrome (ISS), sleep-disordered breathing (SDB), or Parkinson's disease (PD). These false positives are common, may create diagnostic uncertainty, and highlight the need for complementary MSLT measures with high specificity for NC. Methods: Detailed analysis of MSLT findings in 56 NC, 83 PD, 89 SDB, and 23 ISS patients, using receiver operating characteristic curves. Results: A positive MSLT (mean sleep latency ≤ 8.0 minutes and ≥2 SOREMPs) was found in 53 NC (95%), 1 PD (1%), 8 SDB (9%), and 12 ISS patients (52%). MSLT-based differentiation between NC and non-NC patients was best when applying a mean R latency of ≤5 minutes (sensitivity/specificity/positive predictive value [PPV]: 49%/95%/96%) or a mean percentage of sleep stage R ≥ 40% (sensitivity/specificity/PPV: 60%/100%/100%) as cutoffs. When analyzing all 252 naps with SOREMPs in isolation, the combination of both R latency of ≤5 minutes and R percentage of ≥50% yielded a sensitivity/specificity/PPV of 50%/99%/99%. In addition, a sleep stage sequence with R occurring prior to N2 was more common in NC than in non-NC (71% vs. 32%, p < .001), and in combination with R percentage of ≥50% yielded a sensitivity/specificity/PPV of 53%/96%/97%. Conclusions: A better characterization of R sleep by latency, duration, and sleep stage sequence facilitates detection of false positives and, hence, contributes to a higher MSLT specificity in NC.
INTRODUCTION
Narcolepsy with cataplexy (NC)-now referred to as narcolepsy type 1-is a neurological disorder manifesting with excessive daytime sleepiness (EDS) and cataplexy, i.e., the sudden loss of muscle tone with positive emotions. Despite the striking clinical presentation, the diagnosis of NC is often challenging. 1 The measurement of reduced or undetectable cerebrospinal fluid (CSF) hypocretin levels, currently the gold standard to diagnose NC, may not always be available, and the multiple sleep latency test (MSLT) remains therefore of major importance. According to the ICSD-2 diagnostic criteria, the presence of a mean sleep latency of ≤8 minutes with ≥2 sleep onset rapid eye movement (REM or R) sleep periods (SOREMPs) on MSLT-referred to as "positive MSLT"-is required for the diagnosis of narcolepsy. 2 The specificity and positive predictive value (PPV) of a positive MSLT directly depend on the frequency of this MSLT measure in the included control group. In the last two decades, researchers recognized that SOREMPs are common in various disorders with high sleep pressure, [3] [4] [5] [6] including sleep-disordered breathing (SDB), 7 insufficient sleep syndrome (ISS), [8] [9] [10] and Parkinson's disease (PD). [11] [12] [13] [14] [15] Subsequently, the growing number of controls with non-narcoleptic EDS and multiple SOREMPs caused a decrease in PPV from 98%-100% in early studies to 63% in the study of Aldrich et al. that included patients with SDB and other sleep disorders as controls. 4, 16, 17 Today, the MSLT is far more frequently performed in EDS patients with disorders other than NC, and the overall number of false positive MSLT results in many sleep laboratories probably surpass that of true positives.
As a consequence, sleep researchers have put increasing effort to detect additional electrophysiological markers of NC. [17] [18] [19] The presence of a nocturnal SOREMP (R latency ≤ 15 minutes) in the preceding polysomnography has been identified as highly specific (>95%) and was added to the new ICSD-3 diagnostic criteria of NC as an equivalent to SOREMPs on the MSLT. [20] [21] [22] [23] Unfortunately, MSLT markers with similarly high specificity as nocturnal SOREMPs are lacking. If not recognized as false positives, these patients carry a risk of misdiagnosis. When assuming the diagnostic MSLT criteria being stable traits in both narcolepsy with and without cataplexy (referred to as NC type 2 in the ICSD-3 manual), 24 the poor test-retest reliability of multiple SOREMPs in the latter disease type indeed reflects this risk of overdiagnosing NC. 10, 25, 26 In the present study, we performed a detailed electrophysiological analysis in patients with NC, PD, SDB, and ISS. Using receiver operating characteristic (ROC) curves, our main goals were (1) to identify additional MSLT measures that improve the differentiation between true and false positive MSLT results and (2) to recognize whether isolated SOREMP-containing MSLT naps are derived from NC or non-NC patients.
Statement of Significance
The multiple sleep latency test (MSLT) continues to play a major role in the diagnosis of narcolepsy, but the frequent occurrence of positive MSLT results in other sleep and neurological disorders may lead to diagnostic difficulties, including a risk of narcolepsy overdiagnosis. Here, we present four novel MSLT criteria with specificities of 95%-100%. This new set of MSLT criteria will support us in avoiding a misdiagnosis of narcolepsy when sleepiness is of nonnarcoleptic origin.
Participants
Based on a retrospective review of our sleep research database, we included 251 patients examined in our sleep laboratory between 2003 and 2014. This cohort comprised four different groups: 56 patients with NC, 83 patients with PD, 89 patients with SDB, and 23 patients with ISS. All patients underwent nocturnal polysomnography followed by MSLT the next day. In addition, all patients had actigraphy in the 2 weeks preceeding polysomnography, in order to detect chronic sleep deprivation or circadian issues. The diagnostic criteria for NC of the revised 3rd edition of the International Classification of Sleep Disorders (ICSD-3) were fulfilled in each patient. 20 At the moment of the sleep studies, most NC patients were drug-naïve with the exception of five NC patients, who discontinued their REM sleep-suppressing medications 2-3 weeks prior to the sleep examinations. They all had persuasive cataplectic attacks. Measurement of CSF hypocretin levels was done in 45 NC patients, revealing low or undetectable values in all of them. HLA-genotyping was available in 48 NC patients, and all tested patients were positive for the HLA DQB1*06:02 haplotype. We did not exclude two NC patients with clear-cut and frequent cataplexy attacks, despite the lack of CSF hypocretin measurement and HLA-genotyping. Since the distinction of ISS and narcolepsy type 2 (without cataplexy) may be particularly challenging, we adhered to the stringent ICSD-3 diagnostic criteria and included only patients with successful sleep extension during follow-up actigraphy and with subsequent resolution of objective EDS on follow-up MSLT. We identified 49 patients with strong ISS suspicion, who received follow-up examinations to objectively document both sleep extension and resolution of sleepiness. Only 23 patients (47%) fulfilled these criteria and were assigned to the ISS group. Demographic data included age, sex, body mass index (BMI), and race. There was only one African American patient (PD group) and one Latino (SDB group), whereas all other patients were Caucasians. Subjective sleepiness was assessed by the Epworth Sleepiness Scale.
Diagnostic Procedures
Sleep stage scoring of polysomnography and MSLT analyses (Embla N7000, RemLogic v3.2) was performed visually on 30-second epochs, according to standard criteria. 27, 28 Of note, our MSLT procedure was adapted along clinical feasibilitiesin the absence of sufficient technical personnel to guarantee immediate scoring of two simultaneous MSLT studies-and differed from the classical MSLT described by Littner et al., 28 in that the duration of MSLT naps was not individually determined by its sleep latency but was always terminated 20 minutes after "lights out." Likewise, a SOREMP on MSLT was simply defined as the emergence of R sleep during a nap. Out of 252 naps with SOREMPs, R sleep occurred in 247 naps (98%) within ≤15 minutes after sleep onset (i.e., satisfying the classical SOREMP definition), indicating that the discrepancy in MSLT protocols had no relevant impact on SOREMP frequency. The majority of patients (n = 213) received four MSLT naps, scheduled at 2-hour intervals between 9:00 am and 3:00 pm; thirty-eight patients had a fifth MSLT nap if a SOREMP had occurred in the first four naps. For analysis purposes, we used the percentages of each sleep stage with respect to the total sleep time, the latencies to each sleep stage from "lights out," and the number of SOREMPs. Sleep stage sequence was determined by arranging N1, N2, and R sleep according to their latencies from "lights out." To calculate the mean sleep latency of a patient's MSLT, we used the mean latency from lights off to the first of any epoch of sleep, with 20 minutes being the sleep latency in naps when the patient did not sleep at all. For calculation of mean sleep latencies of individual sleep stages, however, we included only those MSLT naps in which a given sleep stage really occurred (instead of equating the absence of a sleep stage with a latency of 20 minutes). We used R latency from lights out instead from sleep onset, because it allowed achieving a higher diagnostic accuracy. The reason is that SOREMP-containing MSLT naps of NC patients have a differential sleep stage sequence from that of non-NC patients, including MSLT naps with direct transition from wake to R sleep (n = 15 in our NC group). If R sleep is the first sleep stage, then R sleep latency from lights out indicates the actual sleep latency, whereas R latency from sleep onset will always be zero.
We ascertained a wide range of polysomnographic parameters, including total sleep time, duration of wakefulness after sleep onset, sleep efficiency with respect to both total registration and total sleep time, apnea-hypopnea index (AHI), percentage of sleep stages N1, N2, N3, and R (with respect to total sleep time), and the latency to the first occurrence of these sleep stages from the beginning of the polysomnographic recording ("lights out"). Nocturnal SOREMP was defined as a latency of ≤15 minutes between sleep onset and the first epoch of R sleep. 21 Technicians awakened the patients after a registration time of roughly 7.5 hours, without postponing polysomnography conclusion in the presence of ongoing R sleep.
Statistical Analysis
Statistical analyses were performed using SPSS (version 23). Group data were described by means and standard deviations. For average comparison of normally distributed data, we used Student's t-test for two groups. A chi-square test was used for nominal data. Correlation analysis of normally distributed data was calculated using Pearson's r coefficient. We applied one-way analysis of variance (ANOVA) to compare continuous measures between the four groups. ROC curve analysis was used to determine optimal MSLT thresholds, and the diagnostic accuracy of these cutoffs was expressed by sensitivity, specificity, and PPV. Significance was accepted at p < .05.
RESULTS
The main demographic and clinical characteristics of the patient groups are summarized in Table 1 , and the polysomnography findings are shown in Table 2 . All but three NC patients had a positive MSLT (95%) ( Table 3) . A positive MSLT was also present in 12 ISS patients (52%), 8 SDB patients (9%), and 1 PD patient (1%). Thus, a positive MSLT detected NC patients with a sensitivity of 95%, whereas specificity and PPV were 89% and 72%, respectively. Nocturnal SOREMPs were common in NC (66%) but did not occur in any SDB or ISS patient. In the whole sample, we could confirm a high diagnostic validity of a nocturnal SOREMP, with a 66% sensitivity, 99% specificity, and 95% PPV. Only one of the three NC patients with negative MSLT had a nocturnal SOREMP. Two PD patients also had an R sleep latency of ≤15 minutes on polysomnography; yet, they had no SOREMPs during MSLT.
When averaging all MSLT naps per group, NC patients entered R sleep much earlier and remained in R sleep much longer than patients of the other three groups ( Figure 1A) . Wakefulness disappeared more rapidly in NC than in the other groups ( Figure 1B ), but the time spent in wakefulness after sleep onset was similar in NC and ISS (0.9 ± 1.1 vs. 1.0 ± 0.9, p = .57), and longer in PD (2.6 ± 2.2 minutes) and SDB (2.2 ± 1.8 minutes). Conversely, all four groups had a similar latency to N2 sleep, but NC remained less in N2 than the other three groups ( Figure 1C ). The amount of N3 sleep was small in all groups ( Figure 1D ).
SOREMPs occurred in 252 of 1042 MSLT naps, and the frequency of naps containing a SOREMP was 75% in NC, 4% in PD, 8% in SDB, and 32% in ISS. In NC-and to a lesser degree in ISS and SDB-there was a significant age-dependent decrease in number of SOREMPs, in mean R duration, and in mean R latency (Table 4) . Sex, BMI, and AHI, on the other hand did not correlate with any of these MSLT parameters. In SDB, AHI mildly correlated with mean latency to N1 (r = −0.10, p = .01), but not with mean latency to R (r = 0.10, p = .68).
Using ROC analysis, we identified several electrophysiological features that were highly specific for NC. First, we compared NC patients with a positive MSLT (n = 53) and non-NC patients with a false positive MSLT (n = 21) (Figure 2A ). The two groups did not differ in age (38 ± 17 years vs. 35 ± 15 years, p = .50), male sex (55% vs. 67%, p = .44), and BMI (26.3 ± 4.9 vs. 25.9 ± 5.1, p = .77). Applying a mean R latency of ≤8 minutes on MSLT as cutoff, 45 NC patients and 3 non-NC patients fulfilled the criterion (sensitivity: 81%, specificity: 86%, PPV: 93%). When further reducing the cutoff to ≤5 minutes, specificity/PPV increased to 95%/96%, but sensitivity dropped to 49%. When applying a mean R percentage of ≥40% on MSLT as cutoff, 32 NC and none of the other patients fulfilled the criterion (sensitivity: 60%, specificity: 100%, PPV: 100%), thus yielding an even higher diagnostic specificity than a nocturnal SOREMP (Figure 3) . Overall, the combination of the standard MSLT criterion with at least one of the proposed specific measures resulted in an increase of specificity/PPV from 89%/72% to 99.5%/97%, respectively (Table 5) .
Second, we analyzed all SOREMP-containing MSLT naps (n = 252) instead of patients with a positive MSLT ( Figure 2B ). An R latency of ≤5 minutes was found in 111 naps of NC patients but in only six naps of non-NC patients (sensitivity: 62%, specificity: 92%, PPV: 95%). An R percentage of ≥50% was found in 117 naps of NC patients and 17 naps of non-NC patients (sensitivity: 66%, specificity: 77%, PPV: 87%). The combination of the two criteria (R latency ≤ 5 minutes and R duration ≥ 50%) further improved the diagnostic accuracy (sensitivity: 50%, specificity: 99%, PPV: 99%) (Figure 3) . Finally, in MSLT naps with SOREMPs, there were specific differences in sleep stage sequence ( Figure 4A ). The presence of R prior to N2 detected NC patients with a sensitivity, specificity, and PPV of 71%, 68%, and 84%, respectively. When combining the presence of R prior to N2 with an R latency of ≤5 minutes, specificity/PPV increased to 92%/94% but sensitivity dropped to 52%. Likewise, the combination of the presence of R prior to N2 with an R percentage of ≥50% had a sensitivity, specificity, and PPV of 53%, 96%, and 97%, respectively ( Figure 4B ).
DISCUSSION
The present study describes novel MSLT criteria that are highly specific for NC. A mean R latency of ≤5 minutes and a mean R percentage of ≥40% represent diagnostic markers that allow differentiating between NC patients and non-NC patients with a "positive MSLT" with a specificity of 95% and 100%, respectively. The complementary application of the proposed measures to the standard MSLT criteria allowed an improvement in specificity/PPV from 89%/72% to 99.5%/97%, respectively. Moreover, when analyzing MSLT naps with SOREMPs in isolation, two combinations-R latency of ≤5 minutes and R percentage of ≥50%; R prior N2 and R percentage of ≥50%-detected naps of NC patients with a specificity of 99% and 96%, respectively. The sensitivities of the four criteria were moderate, varying from 49%-60%. Overall, the diagnostic accuracy of these MSLT criteria is comparable with that reported for nocturnal SOREMPs in both adult and pediatric NC cohorts. 21, 23 Considering that R sleep dysregulation is believed to play a cardinal role in the pathogenesis of most NC symptoms, it is surprising that the diagnostic MSLT criteria have so far only focused on mean sleep latency and number of SOREMPs. Our new MSLT criteria are all based on a better characterization of R sleep by latency, duration, and relative sequence to other sleep stages, and the customary sleep softwares automatically provide these data without need of any additional calculation.
The reported optimization in MSLT specificity comes at the expense of a reduced sensitivity. Ideally, however, the new MSLT parameters should be used in combination with the classical MSLT criteria (mean sleep latency ≤ 8 minutes and ≥2 SOREMPs), thus allowing improving MSLT specificity while retaining the high sensitivity of the latter. Still, a loss in sensitivity might be less of a concern in a condition with high pretest probability, as the correct diagnosis of narcolepsy type 1 can usually be made on the basis of a typical clinical history and with the help of neurochemical and genetic ancillary testing. As recently shown, the delayed diagnosis or entire failure to recognize NC patients mainly arises from a lack of awareness of this rare disease among both health care providers and general population. 29, 30 In the hands of sleep specialists, however, patients with false positive MSLT results are more intriguing, and a reliable way to detect false positives should be of great help. By now, the most convincing way of uncovering a false positive MSLT is to demonstrate its normalization after successful treatment by sleep extension or by continuous positive airway pressure. Yet, the persistence of a positive MSLT after sleep extension is still no proof of NC, because in occasional cases the amount of additional sleep may simply not suffice to dissipate the accumulated sleep debt. The new MSLT markers will, therefore, also facilitate the decision, whether patients with positive MSLT have to be assigned to time-consuming follow-up studies or whether the diagnosis of NC can be accepted. Moreover, because current guidelines for conducting MSLT in patients with suspected NC already specify that patients with obstructive sleep apnea or documented ISS should not have the MSLT to prevent misdiagnosis of NC, our finding of a high prevalence of false positives in these two conditions gives additional support to these MSLT practice guidelines. 28 We confirm the previously observed difference in sleep stage sequence of SOREMP-containing MSLT naps in NC and ISS, with R sleep seldom occurring prior to N2 in the latter group. 9, [31] [32] [33] We now could extend this peculiarity also to patients with SDB. Moreover, the study provides first data on sleep stage sequence in Parkinson's disease, but general conclusions are impeded by the low number of SOREMPs in our cohort. Nevertheless, in these few MSLT naps with SOREMPs, the sleep stage sequence strikingly differed from that seen in SDB and ISS, suggesting that the mechanisms regulating R sleep propensity are distinct in PD. Overall, the analysis of sleep stage sequence in isolation-namely, the occurrence of R sleep prior to N2-yielded only a moderate diagnostic power, with a 71% sensitivity, 68% specificity, and 84% PPV. In combination with an R percentage of ≥50%, however, the specificity of this sleep stage sequence increased to 96%.
Although not the primary goal of the study, our findings reinforce the high diagnostic value of nocturnal SOREMPs in NC. None of the patients with SDB or ISS had a nocturnal SOREMP, not even those 20 patients with a positive MSLT. In their comparison 4, Andlauer et al. reported a frequency of nocturnal SOREMPs of 17.8% among 118 patients with positive MSLT but normal CSF orexin levels; yet, this group was heterogeneous and consisted of patients with narcolepsy type 1, narcolepsy type 2, and other EDS conditions. 21 Since these patients were not further specified by their precise diagnosis, the study failed to provide information regarding the diagnostic power of nocturnal SOREMPs in differentiating NC from EDS conditions with a false positive MSLT. Thus, our study further expands the diagnostic usefulness of nocturnal SOREMPs by demonstrating that it can discern true NC patients from NC mimics. Given that short nocturnal R latencies strongly correlate with higher SOREMP numbers on MSLT, the entire lack of nocturnal SOREMPs in our patients with false positive MSLT is remarkable and might be explained by the strong circadian modulation in R sleep pressure, as shown by the work of Dijk and Czeisler. 33 Accordingly, the homeostatic R pressure in ISS and SDB may cause SOREMPs between 9:00 am and 3:00 pm but not in the late evening, when the circadian R sleep propensity tends to be lowest. 33 In NC, however, the disease-inherent R sleep dysregulation still leads to nocturnal SOREMPs in more than half of the patients, even though researchers regard both homeostatic and circadian processes as preserved in human and rodent NC. [34] [35] [36] We have to acknowledge several limitations. First, the study design was retrospective, and the patient groups differed with regard to age, sex, and BMI. To some extent, such disease-dependent differences are natural and inevitable, but the different age is a critical confounder to our study. Since the number of SOREMPs decreases with advancing age, 37 our MSLT criteria need to be validated in a larger cohort, with inclusion of more elderly ISS patients and younger SDB patients. Still, as the age of the 21 non-narcoleptic patients with positive MSLT was similar to the age of the NC group, the diagnostic validity of our MSLT criteria is likely to be trustworthy. Second, ROC analysis of single MSLT naps-instead of patients-may have caused an overestimated sensitivity and an underestimated specificity, as multiple naps were included in the analysis from the same NC patients. Again, since the main goal was to optimize specificity, this fact additionally highlights the high specificity of our MSLT nap-based cutoffs. Third, the value of our study would be more robust, if we had included a higher number of ISS patients. As ISS is probably the most frequent cause of false positive MSLTs and misdiagnosis of NC, we believe that the rigorous inclusion A mean R latency of ≤8 minutes detected NC patients with 81% sensitivity, 86% specificity, and 93% positive predictive value (PPV), and a mean R latency of ≤5 minutes detected NC patients with 49% sensitivity, 95% specificity, and 96% PPV (red circles in Figure 3A ). Based on this ROC curve, the optimal cutoff of the mean R latency would be ≤7.2 minutes, yielding a 72% sensitivity, 95% specificity, and 97% PPV (asterisk). A mean R percentage ≥40% (red circle in Figure 3B ) detected NC patients with 60% sensitivity, 100% specificity, and 100% PPV. criteria of our ISS group actually represent an important strength of our study. Fourth, our MSLT procedure was not in complete agreement with the standard criteria published in 2005, as we did not ensure a sleep period of precisely 15 minutes. 28 This methodological modification does not influence latencies to N1, N2, R sleep, and sleep stage sequence but potentially the value of R percentage. Still, as we did not choose the absolute duration of R sleep but the R percentage of sleep period as a diagnostic measure, this limitation is unlikely to affect the accuracy of our diagnostic cutoff of ≥40% mean R percentage. Lastly, although increased MSLT specificity is particularly important for narcolepsy without cataplexy, we were not able to recruit such a group from our sleep lab. It will, therefore, be critical for future studies to demonstrate that the presented MSLT criteria are equally valid in patients with narcolepsy without cataplexy.
In conclusion, our study provides diagnostic MSLT parameters that allow differentiating between patients with true positive and false positive MSLT results as well as recognizing whether a SOREMP-containing nap derives from a patient with NC or not. This new set of highly specific MSLT criteria will, therefore, support us in avoiding a misdiagnosis of NC when sleepiness is of non-narcoleptic origin and will be of great value in guiding our diagnostic decisions. . For statistical analysis, we divided all possible sequences in two main groups, depending whether R sleep occurred prior or after N2 sleep; SOREMP-containing naps without achievement of N2 sleep also belonged to the first group (R-N2). Overall, R occurred after N2 in the majority of patients with SDB (87%) and ISS (72%), whereas R occurred usually before N2 in NC (71%) and PD (92%) (p < .001). The box plots in the lower row (B) depict the distribution of the 252 MSLT naps with respect to sleep stage sequence and R percentage. The boxes show median, first and third quartiles, while the end of the whiskers represent the most extreme data points without outliers. A threshold of ≥50% R percentage (dashed red line), combined with a R-N2 sleep stage sequence, detected NC patients with 53% sensitivity, 96% specificity, and 97% positive predictive value. Table 5 -Diagnostic accuracy of the MSLT in 56 patients with narcolepsy with cataplexy (NC) and 195 patients with other sleep/neurological disorders, when using the ICSD-2 criteria in isolation or in combination with at least one additional specific measure (mean R latency ≤ 5 minutes and/or mean R percentage ≥40%). 
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